# GJB1

## Overview
The GJB1 gene encodes the gap junction protein beta 1, also known as connexin 32 (Cx32), which is a transmembrane protein crucial for forming gap junctions that facilitate intercellular communication. These gap junctions are essential for the proper functioning of myelinating Schwann cells in the peripheral nervous system, where they enable the diffusion of ions and small molecules between adjacent cells, thereby maintaining nerve function and homeostasis (Tsai2016Clinical; Scherer1995Connexin32). Cx32 is involved in various biological processes, including metabolic cooperation and electrical coupling, and plays a role in mitochondrial function and cytoskeletal dynamics (Bortolozzi2018What’s). Mutations in the GJB1 gene are associated with X-linked Charcot-Marie-Tooth disease type 1X (CMT1X), a hereditary neuropathy characterized by muscle weakness and sensory loss, highlighting the clinical significance of this gene (Abrams2001Functional; Tsai2016Clinical).

## Structure
The GJB1 gene encodes connexin 32 (Cx32), a protein that forms gap junctions crucial for intercellular communication. The primary structure of Cx32 consists of a sequence of amino acids that form four hydrophobic transmembrane helical domains, two extracellular loops, one cytoplasmic loop, and free N- and C-terminal domains (Kirichenko2021Structure). The secondary and tertiary structures involve the oligomerization of connexin subunits into hexameric complexes known as connexons, which are essential for their function in cell membranes (Kirichenko2021Structure). 

Post-translational modifications, such as phosphorylation, play a significant role in regulating the functions of connexins, including synthesis, transport, and channel gating (Kirichenko2021Structure). Connexin 32 can have multiple splice isoforms, which result from alternative promoter usage and affect the 5' regions of the mRNA without altering the coding region (Kirichenko2021Structure). These structural features and modifications are critical for the proper functioning of Cx32 in the peripheral nervous system, particularly in myelinating Schwann cells, where it is involved in maintaining nerve function and integrity (Bortolozzi2018What’s).

## Function
The GJB1 gene encodes the protein connexin 32 (Cx32), which is integral to the function of myelinating Schwann cells in the peripheral nervous system. Cx32 forms gap junction channels that facilitate the diffusion of ions and small molecules between adjacent cells, playing a crucial role in maintaining nerve function and homeostasis (Tsai2016Clinical; Scherer1995Connexin32). These gap junctions are located in the noncompact myelin regions, such as paranodes and Schmidt-Lanterman incisures, allowing for efficient communication and transport across the myelin sheath (Tomaselli2017Mutations; BaliceGordon1998Functional).

Cx32 is involved in various biological processes, including metabolic cooperation, spatial buffering, and electrical coupling, which are essential for the homeostasis of myelinated axons (Tsai2016Clinical). It also plays a role in the dynamic remodeling and kinetic stability of the actin cytoskeleton, which is crucial for efficient myelination (Bortolozzi2018What’s). Additionally, Cx32 is implicated in mitochondrial function, suggesting a role in optimizing mitochondrial bioenergetics by regulating oxidative phosphorylation rates (Bortolozzi2018What’s). The proper function of Cx32 is vital for maintaining the integrity and function of peripheral nerves, and its dysfunction can lead to peripheral neuropathies such as Charcot-Marie-Tooth disease (Scherer1995Connexin32).

## Clinical Significance
Mutations in the GJB1 gene, which encodes the protein connexin 32, are primarily associated with X-linked Charcot-Marie-Tooth disease type 1X (CMT1X), a hereditary neuropathy characterized by muscle weakness, atrophy, and sensory loss. These mutations can lead to impaired gap junction channel function, affecting ion exchange and metabolic cooperation in myelinating Schwann cells (Abrams2001Functional; Tsai2016Clinical). 

CMT1X is the second most common form of Charcot-Marie-Tooth disease, and mutations in GJB1 can result in a range of clinical manifestations, from mild to severe phenotypes. The severity often correlates with the extent of biophysical dysfunction in the gap junctions, with some mutations causing a complete loss of gap junction permeability and others preserving some function (Tsai2016Clinical). 

Mutations in GJB1 can also lead to central nervous system (CNS) manifestations, particularly when they result in a lack of morphological gap junction plaques or reduced junctional coupling. These mutations can cause episodic CNS clinical syndromes, highlighting the importance of gap junction coupling in the manifestation of CNS symptoms in CMT1X (Abrams2017Loss). 

Overall, GJB1 mutations disrupt normal nerve signal transmission, leading to peripheral neuropathy and, in some cases, CNS involvement (Boerkoel2001Charcot‐Marie‐Tooth).

## Interactions
The GJB1 gene encodes the protein Connexin 32 (Cx32), which is involved in forming gap junctions that facilitate intercellular communication. Cx32 participates in multimeric interactions to form connexons, which are hemichannels that interact with connexons from adjacent cells to form complete gap junction channels. These channels are crucial for communication between Schwann cell nuclei and axons, essential for nerve function (GonzagaJauregui2010GJB1Connexin).

Mutations in GJB1 can lead to dominant-negative interactions, where mutant forms of Cx32 interfere with the function of other connexin isotypes, affecting the protein's function (Boso2020Aberrant). The R142W mutant of Cx32, for example, is mislocalized and retained in the Golgi, potentially due to defective oligomerization. This mutant may have dominant-negative interactions with endogenous mouse Cx32, affecting its oligomerization and leading to mistargeting or degradation (Jeng2006The).

Cx32 also interacts with the actin cytoskeleton and is involved in calcium signaling pathways, which are crucial for myelination and nerve function (Bortolozzi2018What’s). These interactions highlight the complex regulatory mechanisms and potential pathogenic effects of GJB1 mutations.


## References


[1. (Abrams2001Functional) Charles K. Abrams, Mona M. Freidin, Vytas K. Verselis, Michael V.L. Bennett, and Thaddeus A. Bargiello. Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the x-linked form of charcot-marie-tooth disease. Brain Research, 900(1):9–25, May 2001. URL: http://dx.doi.org/10.1016/s0006-8993(00)03327-8, doi:10.1016/s0006-8993(00)03327-8. This article has 66 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0006-8993(00)03327-8)

[2. (Tomaselli2017Mutations) Pedro J. Tomaselli, Alexander M. Rossor, Alejandro Horga, Zane Jaunmuktane, Aisling Carr, Paola Saveri, Giuseppe Piscosquito, Davide Pareyson, Matilde Laura, Julian C. Blake, Roy Poh, James Polke, Henry Houlden, and Mary M. Reilly. Mutations in noncoding regions of gjb1 are a major cause of x-linked cmt. Neurology, 88(15):1445–1453, April 2017. URL: http://dx.doi.org/10.1212/wnl.0000000000003819, doi:10.1212/wnl.0000000000003819. This article has 48 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.0000000000003819)

[3. (Tsai2016Clinical) Pei‐Chien Tsai, De‐Ming Yang, Yi‐Chu Liao, Tai‐Yu Chiu, Hung‐Chou Kuo, Yu‐Ping Su, Yuh‐Cherng Guo, Bing‐Wen Soong, Kon‐Ping Lin, Yo‐Tsen Liu, and Yi‐Chung Lee. Clinical and biophysical characterization of 19 gjb1 mutations. Annals of Clinical and Translational Neurology, 3(11):854–865, September 2016. URL: http://dx.doi.org/10.1002/acn3.347, doi:10.1002/acn3.347. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/acn3.347)

[4. (GonzagaJauregui2010GJB1Connexin) Claudia Gonzaga-Jauregui, Feng Zhang, Charles F. Towne, Sat Dev Batish, and James R. Lupski. Gjb1/connexin 32 whole gene deletions in patients with x-linked charcot–marie–tooth disease. neurogenetics, 11(4):465–470, June 2010. URL: http://dx.doi.org/10.1007/s10048-010-0247-4, doi:10.1007/s10048-010-0247-4. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-010-0247-4)

[5. (Boerkoel2001Charcot‐Marie‐Tooth) Cornelius F. Boerkoel, Hiroshi Takashima, Carlos A. Garcia, Richard K. Olney, John Johnson, Katherine Berry, Paul Russo, Shelley Kennedy, Ahmad S. Teebi, Mena Scavina, Lowell L. Williams, Pedro Mancias, Ian J. Butler, Karen Krajewski, Michael Shy, and James R. Lupski. Charcot‐marie‐tooth disease and related neuropathies: mutation distribution and genotype‐phenotype correlation. Annals of Neurology, 51(2):190–201, December 2001. URL: http://dx.doi.org/10.1002/ana.10089, doi:10.1002/ana.10089. This article has 213 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.10089)

[6. (Abrams2017Loss) Charles K. Abrams, Mikhail Goman, Sarah Wong, Steven S. Scherer, Kleopas A. Kleopa, Alejandro Peinado, and Mona M. Freidin. Loss of coupling distinguishes gjb1 mutations associated with cns manifestations of cmt1x from those without cns manifestations. Scientific Reports, January 2017. URL: http://dx.doi.org/10.1038/srep40166, doi:10.1038/srep40166. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep40166)

[7. (Boso2020Aberrant) Federica Boso, Federica Taioli, Ilaria Cabrini, Tiziana Cavallaro, and Gian Maria Fabrizi. Aberrant splicing in gjb1 and the relevance of 5′ utr in cmtx1 pathogenesis. Brain Sciences, 11(1):24, December 2020. URL: http://dx.doi.org/10.3390/brainsci11010024, doi:10.3390/brainsci11010024. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/brainsci11010024)

[8. (Bortolozzi2018What’s) Mario Bortolozzi. What’s the function of connexin 32 in the peripheral nervous system? Frontiers in Molecular Neuroscience, July 2018. URL: http://dx.doi.org/10.3389/fnmol.2018.00227, doi:10.3389/fnmol.2018.00227. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2018.00227)

[9. (Jeng2006The) Linda Jo Bone Jeng, Rita J. Balice-Gordon, Albee Messing, Kenneth H. Fischbeck, and Steven S. Scherer. The effects of a dominant connexin32 mutant in myelinating schwann cells. Molecular and Cellular Neuroscience, 32(3):283–298, July 2006. URL: http://dx.doi.org/10.1016/j.mcn.2006.05.001, doi:10.1016/j.mcn.2006.05.001. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mcn.2006.05.001)

[10. (Kirichenko2021Structure) E. Yu. Kirichenko, S. N. Skatchkov, and A. M. Ermakov. Structure and functions of gap junctions and their constituent connexins in the mammalian cns. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 15(2):107–119, April 2021. URL: http://dx.doi.org/10.1134/S1990747821020069, doi:10.1134/s1990747821020069. This article has 13 citations.](https://doi.org/10.1134/S1990747821020069)

[11. (BaliceGordon1998Functional) Rita J. Balice-Gordon, Linda J. Bone, and Steven S. Scherer. Functional gap junctions in the schwann cell myelin sheath. The Journal of Cell Biology, 142(4):1095–1104, August 1998. URL: http://dx.doi.org/10.1083/jcb.142.4.1095, doi:10.1083/jcb.142.4.1095. This article has 221 citations.](https://doi.org/10.1083/jcb.142.4.1095)

[12. (Scherer1995Connexin32) SS Scherer, SM Deschenes, YT Xu, JB Grinspan, KH Fischbeck, and DL Paul. Connexin32 is a myelin-related protein in the pns and cns. The Journal of Neuroscience, 15(12):8281–8294, December 1995. URL: http://dx.doi.org/10.1523/jneurosci.15-12-08281.1995, doi:10.1523/jneurosci.15-12-08281.1995. This article has 334 citations.](https://doi.org/10.1523/jneurosci.15-12-08281.1995)